Skip to main content
Equibles
MODD logo

MODD · Modular Medical, Inc.

Track MODD — free

Use MODD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$3.68 +0.26 (+7.60%) At close · Sep 4
Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Even with these proceeds, we do not believe that our cash and cash equivalents will be sufficient to fund our operations for the period of 12 months from the date of issuance of this report, and we would need to raise additional capital. As a result of our expected operating losses and cash burn for the foreseeable future and recurring losses from operations, if we are unable to raise sufficient capital through additional debt or equity arrangements, there will be uncertainty regarding our ability to maintain liquidity sufficient to operate our business effectively, which raises substantial doubt as to our ability to continue as a going concern.”
View the 10-Q filed Aug 14, 2026
Market Cap
$30.00M
Shares
8.15M

MODD metrics

47 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.68
Market cap
$30.00M

Price action

19 metrics
Price change (1W)
+6.4%
Price change (30D)
+67.3%
Price change (3M)
-20.7%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
135.4%
Beta
2.4
RSI (14D)
58.4
Price vs SMA 50
+14.3%
Price vs SMA 200
—
Avg volume (3M)
262,657
Relative volume
1.5
Average dollar volume
$812,862

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
8.15M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.8
reciprocal yield 35.9%
FCF yield
-93.5%
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-93.4%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
$0
Operating profit (TTM)
−$27.29M
Net income (TTM)
−$28.03M
Trailing 12 months
Diluted EPS (TTM)
$-9.85
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$6.93

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+201.2%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-260.4%
Return on assets
-228.7%
Debt / equity
—
Current ratio
3.3
EBITDA (TTM)
−$25.53M
Free cash flow (TTM)
−$28.04M
Quick ratio
3.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$3.92M
Latest balance sheet
Cash & equivalents
$3.92M
Total assets
$12.25M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$24.35M
Capital expenditures (TTM)
$3.69M
R&D (TTM)
$19.21M
SG&A (TTM)
—
Stock compensation (TTM)
$1.50M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
20
13F filer change QoQ
+1
Institutional ownership
21.5%

Short interest

3 metrics
Short interest
5.7%
Latest settlement · 1.3 days to cover
Days to cover
1.3d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
Flagged
Key facts CIK 1074871 CUSIP 60785L306 13F (30d) 19 filings 19 filers Visit website Investor relations